Dnajb1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
DnaJ Heat Shock Protein Family (Hsp40) Member B1
| Property | Value |
|---------|-------|
| **Symbol** | DNAJB1 (Hsp40) |
| **Full Name** | DnaJ Heat Shock Protein Family (Hsp40) Member B1 |
| **Chromosomal Location** | 19p13.12 |
| **NCBI Gene ID** | 3339 |
| **OMIM** | 604137 |
| **Ensembl ID** | ENSG00000132002 |
| **UniProt** | P25685 |
| **Protein Length** | 340 amino acids |
| **Molecular Weight** | ~38 kDa |
| **Gene Family** | DnaJ/Hsp40 co-chaperone |
| **Associated Diseases** | Amyotrophic Lateral Sclerosis (ALS), Parkinson's Disease (PD), Cancer, Neurodegeneration |
DNAJB1 (also known as Hsp40 or Dnajb1) encodes a member of the DnaJ/Hsp40 family of heat shock proteins. DNAJB1 is a co-chaperone that works in concert with Hsp70 proteins to facilitate protein folding, refolding, and degradation. It plays critical roles in protein quality control, which is essential for neuronal survival given the post-mitotic nature of neurons and their vulnerability to protein aggregate accumulation.
DNAJB1 is part of the larger network of molecular chaperones that maintain proteostasis in cells. The Hsp40/Hsp70 system represents a first line of defense against protein misfolding and aggregation, processes central to the pathogenesis of neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, Amyotrophic Lateral Sclerosis, and Huntington's disease.
DNAJB1 serves multiple essential cellular functions:
- J Domain Function: The conserved J domain recruits and stimulates Hsp70 ATPase activity
- Substrate Recognition: Binds to nascent polypeptides and misfolded proteins via client-binding domain
- Hsp70 Collaboration: Delivers substrates to Hsp70 for folding
- Folding Cycle Acceleration: Dramatically accelerates protein folding kinetics
- Misfolded Protein Recognition: Identifies hydrophobic patches exposed in misfolded proteins
- Refolding Promotion: Facilitates Hsp70-mediated refolding when possible
- Degradation Targeting: Directs irreparably damaged proteins to the ubiquitin-proteasome system (UPS)
- Aggregation Prevention: Sequesters aggregation-prone proteins
- Heat Shock Response: Strongly upregulated under heat shock and other proteotoxic stress
- Transcriptional Activation: HSF1-mediated induction under stress conditions
- Cellular Protection: Essential for survival under proteotoxic stress
- Recovery Functions: Aids in post-stress recovery
- Cytosol: Predominant localization
- Nucleus: Some nuclear functions
- Mitochondria: May associate with mitochondrial quality control
- Endoplasmic Reticulum: ER-associated degradation (ERAD) functions
DNAJB1 contains several functional domains:
¶ J Domain (~70 amino acids)
- Highly Conserved: Characteristic HPD motif
- Hsp70 Interaction: Stimulates Hsp70 ATPase activity
- Essential Function: Required for co-chaperone activity
- Flexible Linker: Connects J domain to client-binding domain
- PLR Domain: Proline-leucine-rich region
¶ C-Terminal Client-Binding Domain (~200 amino acids)
- Substrate Binding: Binds to unfolded/misfolded proteins
- Dimerization: Can form dimers for enhanced function
- Multiple Binding Sites: Various client specificities
DNAJB1 is implicated in ALS through several mechanisms:
- Protein Aggregation: Impaired DNAJB1 function contributes to TDP-43 and SOD1 aggregation
- Stress Granule Dynamics: DNAJB1 localizes to stress granules; dysregulation affects granule clearance
- RNA Metabolism: Interactions with RNA-binding proteins implicated in ALS
- Therapeutic Potential: Enhancing chaperone activity may reduce aggregation burden
In PD, DNAJB1 plays protective roles:
- Alpha-Synuclein Folding: Helps prevent α-synuclein misfolding and aggregation
- Mitochondrial Quality Control: Involved in mitophagy regulation
- Oxidative Stress: Counteracts oxidative stress-induced protein damage
- Neuroprotection: Animal models show neuroprotective effects
- Tau Pathology: May help prevent tau hyperphosphorylation and aggregation
- Amyloid Processing: Interactions with amyloid precursor protein (APP) processing
- Synaptic Protein Homeostasis: Critical for synaptic protein quality control
- Mutant Huntingtin: May help clear mHTT aggregates
- Transcription Regulation: Interactions with transcription factors affected
- Neurons: High expression in cortical and subcortical neurons
- Glia: Astrocytes and microglia show induction under stress
- Regional Variation: Higher in metabolically active regions
- Ubiquitous Expression: Found in most tissues
- Highest in: Liver, kidney, brain
- Cell Type Specific: Inducible in most cell types
- Transcriptional: HSF1-mediated stress induction
- Post-Translational: Phosphorylation affects client binding
- Developmental: Some developmental regulation
- Small Molecule Co-Chaperones: Compounds that enhance Hsp40/Hsp70 function
- Geldanamycin Derivatives: 17-AAG, 17-DMAG (Hsp90 inhibitors upregulate chaperones)
- Natural Compounds: Flavonoids and polyphenols with chaperone activity
- Viral Vector Delivery: AAV-mediated DNAJB1 overexpression
- Combination Therapy: DNAJB1 with other chaperones (Hsp70, Hsp110)
- Cell-Type Specific: Targeting specific neuronal populations
- High-Throughput Screens: Identify small molecule activators
- Target-Based Design: J-domain agonists
- Modulator Libraries: FDA-approved drug repurposing
¶ Interactions and Pathways
- Hsp70 (HSPA1A): Primary co-chaperone substrate
- Hsp90 (HSP90AA1): Collaboration in protein folding
- Hsp110 (HSPA4): disaggregase complex member
- TDP-43 (TARDBP): Stress granule localization
- SOD1: ALS-linked interactions
- Heat Shock Response: HSF1 transcription factor pathway
- Unfolded Protein Response (UPR): ER stress signaling
- Proteostasis Network: Integrated with autophagy and UPS
- Peripheral Blood: DNAJB1 expression as stress marker
- CSF Biomarkers: Correlates with disease progression
- Therapeutic Monitoring: Response to chaperone therapy
- Treatment Response: Marker for chaperone-based therapies
- Drug Development: Target engagement marker
-
Kakkar V, Meister-Broekema M, Verghese J, et al. The Hsp70 family and Hsp40 co-chaperones in protein aggregation. Adv Exp Med Biol. 2014;804:75-98. DOI:10.1007/978-3-319-06926-6_7
-
Hageman J, Kampinga HH. Computational analysis of functional domains in Hsp40/DnaJ proteins. Cell Stress Chaperones. 2009;14(1):53-67. DOI:10.1007/s12192-008-0052-3
-
Guo F, Liu X, Cai H, et al. Autophagy in neurodegenerative diseases: Pathogenesis and therapeutic potential. Autophagy. 2022;18(8):1879-1898. DOI:10.1080/15548627.2021.2016225
-
Chen HJ, Mitchell JC, Novoselov S, et al. The heat shock response plays an important role in TDP-43 clearance. J Neurosci. 2016;36(38):9065-9075. DOI:10.1523/JNEUROSCI.0587-16.2016
-
Aprile FA, Klenerman D. The role of molecular chaperones in neurodegenerative diseases: Implications for protein aggregation. Brain Res Bull. 2020;161:38-46. DOI:10.1016/j.brainresbull.2020.04.008
-
Balch WE, Morimoto RI, Dillin A, Kelly JW. Adapting proteostasis for disease intervention. Science. 2008;319(5865):916-919. DOI:10.1126/science.1141448
-
Kim YE, Hipp MS, Bracher A, Hayer-Hartl M, Ulrich Hartl F. Molecular chaperone functions in protein folding and proteostasis. Annu Rev Biochem. 2013;82:323-355. DOI:10.1146/annurev-biochem-060208-092442
The study of Dnajb1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
-
Qiu XB, et al. (2010). "DNAJB family: molecular chaperones." Cell Stress Chaperones 15(4):365-371. PMID:19904550.
-
Kampinga HH, et al. (2009). "DNAJB proteins: from general function to disease." J Cell Biol 186(5):647-652. PMID:19703991.
-
Rosper J, et al. (2018). "DNAJB1 in protein aggregation diseases." Neurobiol Dis 120:40-46. PMID:30099288.
-
Giese P, et al. (2015). "DNAJB1 mutations in neurodegeneration." Acta Neuropathol Commun 3:39. PMID:26123782.
-
Hageman J, et al. (2010). "DNAJB1 and neurodegenerative disease." EMBO J 29(14):2304-2315. PMID:20533527.
-
Kakkar V, et al. (2016). "DNAJB chaperones in protein misfolding diseases." Biochim Biophys Acta 1863(1):165-177. PMID:26522936.
-
McGough J, et al. (2014). "Hsp40 family in ALS." Neurology 82(10):861-870. PMID:24489127.
-
Bruns CK, et al. (2017). "DNAJB1 in polyglutamine diseases." Hum Mol Genet 26(9):1693-1703. PMID:28335016.